ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 646,61
1,44%
Dow Jones
39 331,85
0,00%
DAX
18 332,43
0,99%
Brent Oil
86,245
-0,23%
Bitcoin
60 199,40
-2,95%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Windtree Therapeutics Com (DSCO)

  7. Windtree Therapeutics Com (DSCO) Actualités

DSCO

Discovery labs (DSCO)

Windtree Therapeutics Com
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DSCO
DateHeureSourceTitreSymboleSociété
18/04/201622h53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DSCOWindtree Therapeutics Com
18/04/201614h30PR Newswire (US)Discovery Labs Changes Name to Windtree Therapeutics, Inc. (NASDAQ: WINT)NASDAQ:DSCOWindtree Therapeutics Com
29/03/201623h30Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:DSCOWindtree Therapeutics Com
29/03/201623h30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DSCOWindtree Therapeutics Com
29/03/201612h06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DSCOWindtree Therapeutics Com
24/03/201612h00PR Newswire (US)Discovery Labs Reports Fourth Quarter 2015 Financial Results and Provides Business UpdatesNASDAQ:DSCOWindtree Therapeutics Com
16/03/201622h15PR Newswire (US)Discovery Labs to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Thursday, March 24, 2016NASDAQ:DSCOWindtree Therapeutics Com
16/02/201617h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DSCOWindtree Therapeutics Com
16/02/201615h14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DSCOWindtree Therapeutics Com
04/02/201600h48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSCOWindtree Therapeutics Com
03/02/201622h06PR Newswire (US)Discovery Labs Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:DSCOWindtree Therapeutics Com
02/02/201622h40Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DSCOWindtree Therapeutics Com
01/02/201622h01PR Newswire (US)Discovery Labs Announces Appointment of New Chief Executive Officer and Provides an Update on AEROSURF® Phase 2 ProgramNASDAQ:DSCOWindtree Therapeutics Com
21/01/201622h10PR Newswire (US)Discovery Labs Announces Reverse Stock SplitNASDAQ:DSCOWindtree Therapeutics Com
13/01/201623h18Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:DSCOWindtree Therapeutics Com
13/01/201622h30Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:DSCOWindtree Therapeutics Com
29/12/201522h05PR Newswire (US)Discovery Labs Announces Initiation of AEROSURF® Phase 2b Clinical TrialNASDAQ:DSCOWindtree Therapeutics Com
14/12/201523h22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DSCOWindtree Therapeutics Com
10/12/201513h30PR Newswire (US)Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Presented at the 2015 Hot...NASDAQ:DSCOWindtree Therapeutics Com
02/12/201523h20Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:DSCOWindtree Therapeutics Com
12/11/201513h00PR Newswire (US)Discovery Labs Announces Top Line Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestati...NASDAQ:DSCOWindtree Therapeutics Com
06/11/201514h30PR Newswire (US)Discovery Labs to Announce Results from AEROSURF® Phase 2a Expansion Clinical TrialNASDAQ:DSCOWindtree Therapeutics Com
05/11/201522h15PR Newswire (US)Discovery Labs Provides Business Update and Reports Third Quarter 2015 Financial ResultsNASDAQ:DSCOWindtree Therapeutics Com
21/10/201513h30PR Newswire (US)Discovery Labs Announces Completion of Enrollment in AEROSURF® Phase 2a Dose Expansion TrialNASDAQ:DSCOWindtree Therapeutics Com
10/08/201523h59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DSCOWindtree Therapeutics Com
10/08/201522h45PR Newswire (US)Discovery Labs Provides Business Update and Reports Second Quarter 2015 Financial ResultsNASDAQ:DSCOWindtree Therapeutics Com
03/08/201522h15PR Newswire (US)Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other ...NASDAQ:DSCOWindtree Therapeutics Com
30/07/201513h30PR Newswire (US)Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfacta...NASDAQ:DSCOWindtree Therapeutics Com
22/07/201522h15PR Newswire (US)Discovery Labs Announces Completion of $40.25 Million Public OfferingNASDAQ:DSCOWindtree Therapeutics Com
21/07/201519h39Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DSCOWindtree Therapeutics Com
 Showing the most relevant articles for your search:NASDAQ:DSCO

Dernières Valeurs Consultées

BIT
UC7BDZ
Unicredit Bank
BIT
F14212
Vontobel Financial Produ...
BIT
UC16ZN
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés